Literature DB >> 32690545

Endosomal Trafficking in Alzheimer's Disease, Parkinson's Disease, and Neuronal Ceroid Lipofuscinosis.

Yasir H Qureshi1, Penelope Baez1, Christiane Reitz2,3,4,5.   

Abstract

Neuronal ceroid lipofuscinosis (NCL) is one of the most prevalent neurodegenerative disorders of early life, Parkinson's disease (PD) is the most common neurodegenerative disorder of midlife, while Alzheimer's disease (AD) is the most common neurodegenerative disorder of late life. While they are phenotypically distinct, recent studies suggest that they share a biological pathway, retromer-dependent endosomal trafficking. A retromer is a multimodular protein assembly critical for sorting and trafficking cargo out of the endosome. As a lysosomal storage disease, all 13 of NCL's causative genes affect endolysosomal function, and at least four have been directly linked to retromer. PD has several known causative genes, with one directly linked to retromer and others causing endolysosomal dysfunction. AD has over 25 causative genes/risk factors, with several of them linked to retromer or endosomal trafficking dysfunction. In this article, we summarize the emerging evidence on the association of genes causing NCL with retromer function and endosomal trafficking, review the recent evidence linking NCL genes to AD, and discuss how NCL, AD, and PD converge on a shared molecular pathway. We also discuss this pathway's role in microglia and neurons, cell populations which are critical to proper brain homeostasis and whose dysfunction plays a key role in neurodegeneration.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  Alzheimer's disease (AD); NCL genes; Parkinson's disease; Vos29); Vps26; endocytic pathway; endosomal trafficking; genetic and cell biology findings on Alzheimer's disease; microglia; retromer defects; retromer proteins (Vps35; retromer viral vectors for AD gene therapy

Mesh:

Substances:

Year:  2020        PMID: 32690545      PMCID: PMC7491951          DOI: 10.1128/MCB.00262-20

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  150 in total

Review 1.  Pathoanatomy of Parkinson's disease.

Authors:  H Braak; E Braak
Journal:  J Neurol       Date:  2000-04       Impact factor: 4.849

2.  A novel p.Leu(381)Phe mutation in presenilin 1 is associated with very early onset and unusually fast progressing dementia as well as lysosomal inclusions typically seen in Kufs disease.

Authors:  Natalia Dolzhanskaya; Michael A Gonzalez; Fiorella Sperziani; Shannon Stefl; Jeffrey Messing; Guang Y Wen; Emil Alexov; Stephan Zuchner; Milen Velinov
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

Review 3.  The use of pharmacological retromer chaperones in Alzheimer's disease and other endosomal-related disorders.

Authors:  Diego E Berman; Dagmar Ringe; Greg A Petsko; Scott A Small
Journal:  Neurotherapeutics       Date:  2015-01       Impact factor: 7.620

4.  Cathepsin F mutations cause Type B Kufs disease, an adult-onset neuronal ceroid lipofuscinosis.

Authors:  Katherine R Smith; Hans-Henrik M Dahl; Laura Canafoglia; Eva Andermann; John Damiano; Michela Morbin; Amalia C Bruni; Giorgio Giaccone; Patrick Cossette; Paul Saftig; Joachim Grötzinger; Michael Schwake; Frederick Andermann; John F Staropoli; Katherine B Sims; Sara E Mole; Silvana Franceschetti; Noreen A Alexander; Jonathan D Cooper; Harold A Chapman; Stirling Carpenter; Samuel F Berkovic; Melanie Bahlo
Journal:  Hum Mol Genet       Date:  2013-01-07       Impact factor: 6.150

5.  Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenilin mutations.

Authors:  A M Cataldo; C M Peterhoff; J C Troncoso; T Gomez-Isla; B T Hyman; R A Nixon
Journal:  Am J Pathol       Date:  2000-07       Impact factor: 4.307

6.  Progranulin Deficiency Promotes Circuit-Specific Synaptic Pruning by Microglia via Complement Activation.

Authors:  Hansen Lui; Jiasheng Zhang; Stefanie R Makinson; Michelle K Cahill; Kevin W Kelley; Hsin-Yi Huang; Yulei Shang; Michael C Oldham; Lauren Herl Martens; Fuying Gao; Giovanni Coppola; Steven A Sloan; Christine L Hsieh; Charles C Kim; Eileen H Bigio; Sandra Weintraub; Marek-Marsel Mesulam; Rosa Rademakers; Ian R Mackenzie; William W Seeley; Anna Karydas; Bruce L Miller; Barbara Borroni; Roberta Ghidoni; Robert V Farese; Jeanne T Paz; Ben A Barres; Eric J Huang
Journal:  Cell       Date:  2016-04-21       Impact factor: 41.582

7.  Progranulin protects against amyloid β deposition and toxicity in Alzheimer's disease mouse models.

Authors:  S Sakura Minami; Sang-Won Min; Grietje Krabbe; Chao Wang; Yungui Zhou; Rustam Asgarov; Yaqiao Li; Lauren H Martens; Lisa P Elia; Michael E Ward; Lennart Mucke; Robert V Farese; Li Gan
Journal:  Nat Med       Date:  2014-09-28       Impact factor: 53.440

Review 8.  Microglial Progranulin: Involvement in Alzheimer's Disease and Neurodegenerative Diseases.

Authors:  Anarmaa Mendsaikhan; Ikuo Tooyama; Douglas G Walker
Journal:  Cells       Date:  2019-03-11       Impact factor: 6.600

9.  Molecular correlates of axonal and synaptic pathology in mouse models of Batten disease.

Authors:  Catherine Kielar; Thomas M Wishart; Alice Palmer; Sybille Dihanich; Andrew M Wong; Shannon L Macauley; Chun-Hung Chan; Mark S Sands; David A Pearce; Jonathan D Cooper; Thomas H Gillingwater
Journal:  Hum Mol Genet       Date:  2009-07-29       Impact factor: 6.150

10.  Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease.

Authors:  J C Lambert; C A Ibrahim-Verbaas; D Harold; A C Naj; R Sims; C Bellenguez; A L DeStafano; J C Bis; G W Beecham; B Grenier-Boley; G Russo; T A Thorton-Wells; N Jones; A V Smith; V Chouraki; C Thomas; M A Ikram; D Zelenika; B N Vardarajan; Y Kamatani; C F Lin; A Gerrish; H Schmidt; B Kunkle; M L Dunstan; A Ruiz; M T Bihoreau; S H Choi; C Reitz; F Pasquier; C Cruchaga; D Craig; N Amin; C Berr; O L Lopez; P L De Jager; V Deramecourt; J A Johnston; D Evans; S Lovestone; L Letenneur; F J Morón; D C Rubinsztein; G Eiriksdottir; K Sleegers; A M Goate; N Fiévet; M W Huentelman; M Gill; K Brown; M I Kamboh; L Keller; P Barberger-Gateau; B McGuiness; E B Larson; R Green; A J Myers; C Dufouil; S Todd; D Wallon; S Love; E Rogaeva; J Gallacher; P St George-Hyslop; J Clarimon; A Lleo; A Bayer; D W Tsuang; L Yu; M Tsolaki; P Bossù; G Spalletta; P Proitsi; J Collinge; S Sorbi; F Sanchez-Garcia; N C Fox; J Hardy; M C Deniz Naranjo; P Bosco; R Clarke; C Brayne; D Galimberti; M Mancuso; F Matthews; S Moebus; P Mecocci; M Del Zompo; W Maier; H Hampel; A Pilotto; M Bullido; F Panza; P Caffarra; B Nacmias; J R Gilbert; M Mayhaus; L Lannefelt; H Hakonarson; S Pichler; M M Carrasquillo; M Ingelsson; D Beekly; V Alvarez; F Zou; O Valladares; S G Younkin; E Coto; K L Hamilton-Nelson; W Gu; C Razquin; P Pastor; I Mateo; M J Owen; K M Faber; P V Jonsson; O Combarros; M C O'Donovan; L B Cantwell; H Soininen; D Blacker; S Mead; T H Mosley; D A Bennett; T B Harris; L Fratiglioni; C Holmes; R F de Bruijn; P Passmore; T J Montine; K Bettens; J I Rotter; A Brice; K Morgan; T M Foroud; W A Kukull; D Hannequin; J F Powell; M A Nalls; K Ritchie; K L Lunetta; J S Kauwe; E Boerwinkle; M Riemenschneider; M Boada; M Hiltuenen; E R Martin; R Schmidt; D Rujescu; L S Wang; J F Dartigues; R Mayeux; C Tzourio; A Hofman; M M Nöthen; C Graff; B M Psaty; L Jones; J L Haines; P A Holmans; M Lathrop; M A Pericak-Vance; L J Launer; L A Farrer; C M van Duijn; C Van Broeckhoven; V Moskvina; S Seshadri; J Williams; G D Schellenberg; P Amouyel
Journal:  Nat Genet       Date:  2013-10-27       Impact factor: 38.330

View more
  2 in total

1.  Interruption of endolysosomal trafficking leads to stroke brain injury.

Authors:  Dong Yuan; Kurt Hu; Chun Mun Loke; Hironori Teramoto; Chunli Liu; Bingren Hu
Journal:  Exp Neurol       Date:  2021-08-05       Impact factor: 5.330

2.  Impaired Retromer Function in Niemann-Pick Type C Disease Is Dependent on Intracellular Cholesterol Accumulation.

Authors:  Kristina Dominko; Ana Rastija; Sandra Sobocanec; Lea Vidatic; Sarah Meglaj; Andrea Lovincic Babic; Birgit Hutter-Paier; Alessio-Vittorio Colombo; Stefan F Lichtenthaler; Sabina Tahirovic; Silva Hecimovic
Journal:  Int J Mol Sci       Date:  2021-12-09       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.